Managing tuberculosis in patients with diabetes mellitus: why we care and what we know

被引:0
|
作者
Jeon, Christie Y. [1 ]
Murray, Megan B. [2 ,3 ]
Baker, Meghan A. [4 ,5 ,6 ]
机构
[1] Columbia Univ, Sch Nursing, New York, NY 10032 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA
[4] Harvard Univ, Dept Populat Med, Sch Med, Boston, MA USA
[5] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
关键词
antibiotic treatment; diabetes mellitus; glucose control; tuberculosis; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PHARMACOKINETICS; PREVALENCE; RISK; MICE; SUSCEPTIBILITY; CONVERGENCE; EPIDEMICS; INFECTION;
D O I
10.1586/ERI.12.75
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
As the global prevalence of diabetes mellitus (DM) increases, especially in low-to-middle income countries where tuberculosis (TB) remains endemic, we will encounter a growing number of TB patients with DM. This is a major concern for TB control programs, clinicians and patients alike because DM patients are at an increased risk of TB and are more likely to face poor TB treatment outcomes, including treatment failure, relapse and even death. Priority should be placed on early detection of both diseases through active screening, monitoring of adherence to medications for both diseases, and integration of TB and DM management strategies that would facilitate the provision of more comprehensive services that TB patients with DM require.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 50 条
  • [41] What Do We Know About How to Treat Tuberculosis?
    Marais, Ben J.
    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN VIII, 2011, 719 : 171 - 184
  • [42] Latent tuberculosis infection: What we know about its genetic control?
    Kondratieva, Tatiana
    Azhikina, Tatyana
    Nikonenko, Boris
    Kaprelyants, Arseny
    Apt, Alexander
    TUBERCULOSIS, 2014, 94 (05) : 462 - 468
  • [43] Metabolic syndrome - What we know and what we don't know
    Ritz, Eberhard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1619 - 1623
  • [44] Transmission of Ebola Viruses: What We Know and What We Do Not Know
    Osterholm, Michael T.
    Moore, Kristine A.
    Kelley, Nicholas S.
    Brosseau, Lisa M.
    Wong, Gary
    Murphy, Frederick A.
    Peters, Clarence J.
    LeDuc, James W.
    Russell, Phillip K.
    Van Herp, Michel
    Kapetshi, Jimmy
    Muyembe, Jean-Jacques T.
    Ilunga, Benoit Kebela
    Strong, James E.
    Grolla, Allen
    Wolz, Anja
    Kargbo, Brima
    Kargbo, David K.
    Formenty, Pierre
    Sanders, David Avram
    Kobinger, Gary P.
    MBIO, 2015, 6 (02):
  • [45] Fecal Microbiota Transplantation: What We Know and What We Need to Know
    Surawicz, Christina M.
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (09) : 662 - 663
  • [46] Anomalous coronary arteries: What we know and what we do not know
    Port, Steven
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 235 - 238
  • [47] Inflammation and psychopathology: what we now know, and what we need to know
    Uddin, Monica
    Diwadkar, Vaibhav A.
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2014, 49 (10) : 1537 - 1539
  • [48] Contagious itch: what we know and what we would like to know
    Schut, C.
    Grossman, S.
    Gieler, U.
    Kupfer, J.
    Yosipovitch, G.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2015, 9
  • [49] Bioprosthetic valve thrombosis: What we know and what we need to know
    Egbe, Alexander C.
    Connolly, Heidi M.
    Schaff, Hartzell V.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (04): : 975 - 978
  • [50] Zika Virus in Semen: What We Know and What We Need to Know
    Gornet, Megan E.
    Bracero, Nabal J.
    Segars, James H.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2016, 34 (05) : 285 - 292